
Aurora operates as Axon's fund-of-funds division, specializing in investments with top-performing General Partners (GPs) within the ICT and life sciences sectors. The primary objective is to offer Limited Partners (LPs) exposure to the venture capital market through a meticulously managed and diversified portfolio strategy. In addition to primary investments in funds, Aurora enhances its portfolio strategy with secondary transactions in funds and co-investments in successful portfolio companies. This approach aims to maximize investment returns and mitigate risk across the venture capital landscape.